Guggulsterone, a Classical Lipid‐Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer
Lipids · 2026-05 · 61 (3) · 279-284
DOI: 10.1002/lipd.70030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lipids, online erschienen am 01.12.2025. Verfasst von Nila Ganamurali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Helix Research Lab, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chenna…. Hauptthemen laut MEDLINE: Pregnenediones, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Dysregulated lipid metabolism fuels cancer progression through enhanced lipogenesis, cholesterol synthesis, and fatty acid oxidation. Herbal bioactives provide multi‐targeted molecular interventions capable of restoring lipid homeostasis while minimizing toxicity. Guggulsterone (GS), a plant‐derived steroidal compound from Commiphora mukul , exemplifies this paradigm by modulating key regulators such as ATP citrate lyase (ACLY), acetyl‐CoA carboxylase (ACC), farnesoid X receptor (FXR), and AMP‐activated protein kinase (AMPK). Through these actions, it suppresses oncogenic lipid signaling, reprograms the tumor microenvironment, and enhances apoptotic sensitivity. This article outlines the molecular underpinnings of GS's lipid‐lowering and antitumor effects, emphasizing its potential as a pharmacological scaffold for metabolic reprogramming in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Helix Research Lab, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.
- Department of Gynaecologic Oncology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.
ORCID-Profile: Nila Ganamurali, Sarvesh Sabarathinam
Zitieren
APA
Ganamurali, N., Devarajan, M., & Sabarathinam, S. (2026). Guggulsterone, a Classical Lipid‐Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer. Lipids, 61(3), 279-284. https://doi.org/10.1002/lipd.70030
Vancouver
Ganamurali N, Devarajan M, Sabarathinam S. Guggulsterone, a Classical Lipid‐Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer. Lipids. 2026;61(3):279-284. doi:10.1002/lipd.70030
BibTeX
@article{Ganamurali2026,
author = {Ganamurali, Nila and Devarajan, Mohanapriya and Sabarathinam, Sarvesh},
title = {Guggulsterone, a Classical Lipid‐Lowering Phytosteroidal FXR Antagonist, as a Modulator of Lipid Signaling and Metabolic Reprogramming in Cancer},
journal = {Lipids},
year = {2026},
volume = {61},
number = {3},
pages = {279--284},
doi = {10.1002/lipd.70030}
}
EUVIMED